275 related articles for article (PubMed ID: 33098048)
1. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
[TBL] [Abstract][Full Text] [Related]
2. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
[TBL] [Abstract][Full Text] [Related]
5. Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells.
Wernicke C; Hellmann J; Finckh U; Rommelspacher H
Pharmacol Rep; 2010; 62(4):649-63. PubMed ID: 20885005
[TBL] [Abstract][Full Text] [Related]
6.
El-Habta R; Af Bjerkén S; Virel A
Neurol Res; 2024 May; 46(5):406-415. PubMed ID: 38498979
[TBL] [Abstract][Full Text] [Related]
7. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.
Kim S; Lim J; Bang Y; Moon J; Kwon MS; Hong JT; Jeon J; Seo H; Choi HJ
Mol Neurobiol; 2018 Feb; 55(2):1607-1619. PubMed ID: 28190238
[TBL] [Abstract][Full Text] [Related]
9. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.
Coccini T; Vecchio S; Crevani M; De Simone U
Neurotox Res; 2019 Jan; 35(1):49-62. PubMed ID: 29934755
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
Lim J; Choi HS; Choi HJ
J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells.
Gómez-Santos C; Ambrosio S; Ventura F; Ferrer I; Reiriz J
Brain Res; 2002 Dec; 958(1):152-60. PubMed ID: 12468040
[TBL] [Abstract][Full Text] [Related]
13. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
14. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
[TBL] [Abstract][Full Text] [Related]
15. A cell culture model for investigation of synapse influenceability: epigenetics, expression and function of gene targets important for synapse formation and preservation in SH-SY5Y neuroblastoma cells differentiated by retinoic acid.
Jahn K; Wieltsch C; Blumer N; Mehlich M; Pathak H; Khan AQ; Hildebrandt H; Frieling H
J Neural Transm (Vienna); 2017 Nov; 124(11):1341-1367. PubMed ID: 28887651
[TBL] [Abstract][Full Text] [Related]
16. The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
Jantas D; Roman A; Kuśmierczyk J; Lorenc-Koci E; Konieczny J; Lenda T; Lasoń W
Neurotox Res; 2013 Jul; 24(1):41-54. PubMed ID: 23307753
[TBL] [Abstract][Full Text] [Related]
17. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists.
Presgraves SP; Ahmed T; Borwege S; Joyce JN
Neurotox Res; 2004; 5(8):579-98. PubMed ID: 15111235
[TBL] [Abstract][Full Text] [Related]
18. Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression.
Magalingam KB; Somanath SD; Md S; Haleagrahara N; Fu JY; Selvaduray KR; Radhakrishnan AK
Nutr Res; 2022 Feb; 98():27-40. PubMed ID: 35065349
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profile of NF-κB, Nrf2, Glycolytic, and p53 Pathways During the SH-SY5Y Neuronal Differentiation Mediated by Retinoic Acid.
de Bittencourt Pasquali MA; de Ramos VM; Albanus RDO; Kunzler A; de Souza LHT; Dalmolin RJS; Gelain DP; Ribeiro L; Carro L; Moreira JCF
Mol Neurobiol; 2016 Jan; 53(1):423-435. PubMed ID: 25465239
[TBL] [Abstract][Full Text] [Related]
20. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
